| ANZCX | FCVSX | ANZCX / FCVSX | |
| Total Expense Ratio | 1.73 | 0.64 | 270% |
| Annual Report Gross Expense Ratio | 1.83 | 0.64 | 286% |
| Fund Existence | 16 years | 40 years | - |
| Gain YTD | 11.296 | 16.640 | 68% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 0 | - |
| Min. Initial Investment IRA | N/A | 2500 | - |
| Net Assets | 1.6B | 2.45B | 65% |
| Annual Yield % from dividends | 0.24 | 2.03 | 12% |
| Returns for 1 year | 10.06 | 14.54 | 69% |
| Returns for 3 years | 43.25 | 44.67 | 97% |
| Returns for 5 years | -1.30 | 8.42 | -15% |
| Returns for 10 years | 58.79 | 94.09 | 62% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BSCR | 19.62 | 0.01 | +0.05% |
| Invesco BulletShares 2027 Corp Bd ETF | |||
| TFJL | 18.75 | 0.01 | +0.03% |
| Innovator 20 Year Treasury Bond 5 Floor ETF | |||
| XJUL | 41.72 | -0.03 | -0.06% |
| FT Vest U.S. Eq Enh & ModBufETF-Jul | |||
| VIXM | 13.20 | -0.10 | -0.75% |
| ProShares VIX Mid-Term Futures | |||
| LABU | 303.55 | -2.31 | -0.76% |
| Direxion Daily S&P Biotech Bull 3X ETF | |||